Company / Operating Income per Share
Compass Therapeutics, Inc. Operating Income per Share History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$0.41
FY2024
5-year range
-$1.30 / -$0.33
FY2020-FY2024
Trend
-4.2%
vs FY2023
Sector context
#69 of 199
Health Care
What the data says
At $-0.41, Compass Therapeutics, Inc.'s operating income per share ranks #69 of 199 in the Health Care sector. Operating Income per Share has fluctuated over the past 7 years, ranging from $-5.09 in FY2019 to $-0.01 in FY2018.
Based on SEC 10-K filings.
-0.41 in FY2024.
Declined from $-0.33 to $-0.41 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#69 of 199 in Health CareTop 35% of 199This company -$0.41 Sector average -$3.34
▼
+87.7% above sector average
Key checks
Key Insights
- In FY2024, operating income per share decreased 4.2% year-over-year.
- Ranks #69 out of 199 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2018.
- Lowest operating income per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$0.41 | -4.2% |
| FY2023 | -$0.39 | -19.6% |
| FY2022 | -$0.33 | +74.7% |
| FY2021 | -$1.30 | -44.1% |
| FY2020 | -$0.90 | +82.2% |
| FY2019 | -$5.09 | -77576.7% |
| FY2018 | -$0.01 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026